People of all ages benefit from drugs to lower blood pressure

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Epidemiology

Background:

• High blood pressure (hypertension) is a major risk factor for cardiovascular disease (CVD) and mortality.
• Pharmacological interventions are widely used to manage hypertension.
• Understanding the efficacy of these treatments across diverse populations is crucial for optimizing cardiovascular prevention strategies.

Purpose of the Study:

• To conduct a meta-analysis of individual participant data to evaluate the effects of blood pressure-lowering pharmacotherapy on cardiovascular outcomes.
• To stratify treatment effects by age and baseline blood pressure levels.
• To determine the net benefit of blood pressure-lowering treatments in preventing CVD and death.

Main Methods:

• Individual participant-level data from multiple randomized controlled trials were pooled.
• Meta-analysis techniques were employed to analyze the aggregated data.
• Effects were stratified by age groups and baseline blood pressure categories.

Main Results:

• Blood pressure-lowering pharmacotherapy significantly reduces the risk of cardiovascular events and death.
• Treatment benefits were observed consistently across all age groups studied.
• The magnitude of benefit was generally proportional to the achieved blood pressure reduction, with significant benefits even at lower baseline blood pressure levels.

Conclusions:

• Blood pressure-lowering medications are effective in preventing cardiovascular disease and death in individuals of all ages.
• The benefits of pharmacotherapy extend to individuals across a wide range of baseline blood pressure.
• These findings support the broad application of blood pressure-lowering treatments for primary and secondary cardiovascular prevention.